Skip to content

Clinical trials

Phase 1 Hematologic Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Phase: Phase 1 Country / region: France Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20171
20202
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anaveon AG1
Chroma Therapeutics1
Eli Lilly and Company1
MaaT Pharma1
Nantes University Hospital1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases6
Multiple Myeloma2
Bone Marrow Diseases1
Disease1
Leukemia1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid1
Leukemia, Myeloid, Acute1
Leukemia, Myelomonocytic, Chronic1
Lymphoma, B-Cell1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.